Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Korean Regulatory Overhaul To Cut Drug RnD, Approval Time

This article was originally published in SRA

Executive Summary

The South Korean government has unveiled a series of regulatory reforms that are designed to step up the competitiveness of the pharma industry and supply drugs in time for public health emergencies.

Advertisement

Related Content

2016 Review: Despite Political Woes, Korea Pro-Pharma Policies Stay Intact
Advertisement
UsernamePublicRestriction

Register